ANGIOGENESIS BIOMARKER DECREASED

This adverse event was reported 6 times

ANGIOGENESIS BIOMARKER DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAGRAXOFUSP 4 0.0074
1 IBUPFROFEN 1 0.0000
2 IBUPROFEN TABLETS USP, 200MG 1 0.0000
3 IBUPROFEN ORAL 1 0.0000
4 IBUPROFEN CAPSULES 200 MG 1 0.0000
5 IBUPROFEN 1 0.0000
6 LENALIDOMIDE 1 0.0000
See all drugs enriched for association with ANGIOGENESIS BIOMARKER DECREASED

These drug classes are most commonly taken by patients reporting ANGIOGENESIS BIOMARKER DECREASED:

# Drug class Count
0 CD123 Interaction [EPC] 4
1 Cytotoxin [EPC] 4
2 Nonsteroidal Anti-inflammatory Drug [EPC] 1
3 Thalidomide Analog [EPC] 1
See all common drug classes associated with ANGIOGENESIS BIOMARKER DECREASED

ANGIOGENESIS BIOMARKER DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD123 Interaction [EPC] 4 0.0074
1 Thalidomide Analog [EPC] 1 0.0000
2 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with ANGIOGENESIS BIOMARKER DECREASED